SCHEMBL6834072

SCHEMBL6834072

Cc1ccc(CC(=O)Nc2cccc3cc(C(=O)Nc4ccc(C#N)cc4C(=O)O)[nH]c23)cc1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.41
MAPT P10636 2/20 0.41
MEN1 O00255 1/20 0.41
HTT P42858 1/20 0.41
KMT2A Q03164 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
PARP14 Q460N5 2/20 0.40
LMNA P02545 1/20 0.39
PLK1 P53350 4/20 0.39
NPC1 O15118 1/20 0.39
MAPK1 P28482 1/20 0.39
RAB9A P51151 1/20 0.39
PLK3 Q9H4B4 1/20 0.39
NSD2 O96028 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
KDM4E B2RXH2 1/20 0.39
PKM P14618 1/20 0.39
ALB P02768 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6834504 0.93 LMNA (0.47) ALDH1A1MEN1KMT2APARP14LMNA
SCHEMBL6833157 0.92 PARP14 (0.42) ALDH1A1MEN1KMT2APARP14LMNA
SCHEMBL6833683 0.92 NR1H4 (0.48) ALDH1A1
SCHEMBL6833766 0.91 PARP14 (0.43) ALDH1A1MEN1KMT2APARP14LMNA
SCHEMBL6835671 0.91 LMNA (0.39) MAPTPARP14LMNAMAPK1PKM
SCHEMBL6834079 0.91 NHERF1 (0.44) ALDH1A1MEN1KMT2APARP14LMNA
SCHEMBL6834350 0.91 ALDH1A1 (0.50) ALDH1A1MAPTMEN1KMT2APARP14
SCHEMBL6834134 0.91 IDO1 (0.43) ALDH1A1MAPTTDP1PARP14LMNA
SCHEMBL6833113 0.90 SMN1; SMN2 (0.46) ALDH1A1MAPTMEN1KMT2ALMNA
SCHEMBL6833337 0.90 RXFP1 (0.45) PARP14LMNAPLK1ALB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040110802-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-06-10 US claimed
US-20040110802-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040110802-A1 Antibacterial benzoic acid derivatives GABRD, GABBR1, GABRA1 ALDH1A1 170/4885MAPT 4759/4885MEN1 4132/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.